Skip to main content
. 2017 Jul 20;143(7):691–699. doi: 10.1001/jamaoto.2017.0012

Table 2. Factors Associated With Receipt of CRT in the 6900 Study Patients.

Factor Multivariate Analysis for Receiving CRT, Adjusted Odds Ratio (95% CI)a
Age, y
≤50 1 [Reference]
51-60 1.18 (0.99-1.40)
61-70 1.24 (1.04-1.49)
>70 1.38 (1.15-1.68)
Sex
Female 1 [Reference]
Male 1.31 (1.16-1.49)
Year of diagnosis
2004-2006 1 [Reference]
2007-2009 0.79 (0.68-0.91)
2010-2012 0.48 (0.42-0.46)
Distance, miles
<10 1 [Reference]
10-19 0.63 (0.54-0.74)
20-29 0.67 (0.55-0.81)
≥30 0.49 (0.42-0.57)
Facility
Academic 1 [Reference]
Comprehensive community cancer program 2.65 (2.33-3.01)
Community or integrated network cancer program 2.54 (2.15-3.01)
Unknown 1.04 (0.72-1.49)
Comorbidity index
1 1 [Reference]
2 0.60 (0.51-0.71)
3 0.81 (0.61-1.06)
Clinical T stage
cT1-cT2 1 [Reference]
cT3-cT4a 2.11 (1.85-2.41)
Clinical N stage
cN0-cN1 1 [Reference]
cN2a-cN2c 1.81 (1.62-2.04)
Site
Oral tongue 1.78 (1.58-2.01)
Other mouth 1 [Reference]

Abbreviation: CRT, chemoradiotherapy.

a

Multivariate model included age, sex, year of diagnosis, distance from facility, facility type, comorbidity index, clinical T stage, clinical N stage, and site.